| protein modification process | GO:0036211 | 438 | 0.066 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.048 | Human |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.047 | |
| regulation of cell cycle | GO:0051726 | 291 | 0.047 | Human |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.043 | Human |
| cellular protein modification process | GO:0006464 | 438 | 0.042 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.039 | Human |
| nuclear division | GO:0000280 | 332 | 0.039 | |
| cell death | GO:0008219 | 279 | 0.038 | Human |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.037 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.037 | |
| chromosome organization | GO:0051276 | 360 | 0.036 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.033 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.032 | |
| establishment of protein localization | GO:0045184 | 163 | 0.032 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.030 | Human |
| regulation of cell cycle process | GO:0010564 | 181 | 0.029 | Human |
| regulation of organelle organization | GO:0033043 | 196 | 0.028 | Human |
| post embryonic appendage morphogenesis | GO:0035120 | 385 | 0.027 | |
| protein localization | GO:0008104 | 284 | 0.027 | |
| oxoacid metabolic process | GO:0043436 | 103 | 0.027 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 267 | 0.026 | |
| intracellular transport | GO:0046907 | 228 | 0.025 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.024 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.023 | |
| organelle assembly | GO:0070925 | 198 | 0.023 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.023 | Human |
| death | GO:0016265 | 284 | 0.023 | Human |
| dna damage checkpoint | GO:0000077 | 78 | 0.022 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.022 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.022 | |
| endocytosis | GO:0006897 | 310 | 0.022 | |
| catabolic process | GO:0009056 | 409 | 0.022 | |
| chromatin organization | GO:0006325 | 207 | 0.021 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.021 | Human |
| phosphorylation | GO:0016310 | 294 | 0.021 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.021 | Human |
| regulation of catabolic process | GO:0009894 | 170 | 0.020 | Human |
| single organism intracellular transport | GO:1902582 | 207 | 0.020 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.020 | |
| chemotaxis | GO:0006935 | 249 | 0.020 | |
| cellular protein localization | GO:0034613 | 160 | 0.020 | |
| mitotic nuclear division | GO:0007067 | 213 | 0.020 | |
| small molecule metabolic process | GO:0044281 | 305 | 0.020 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.020 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.019 | Human |
| dna metabolic process | GO:0006259 | 227 | 0.019 | |
| camera type eye development | GO:0043010 | 4 | 0.019 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.018 | Human |
| cytoplasmic transport | GO:0016482 | 130 | 0.018 | |
| rna processing | GO:0006396 | 147 | 0.018 | |
| cell division | GO:0051301 | 248 | 0.018 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 109 | 0.018 | Human |
| heterocycle catabolic process | GO:0046700 | 166 | 0.018 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.017 | |
| organic substance transport | GO:0071702 | 257 | 0.017 | |
| cellular catabolic process | GO:0044248 | 372 | 0.017 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 0 | 0.017 | |
| nuclear transport | GO:0051169 | 72 | 0.017 | |
| cellular macromolecule localization | GO:0070727 | 220 | 0.017 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.017 | |
| protein phosphorylation | GO:0006468 | 169 | 0.017 | |
| central nervous system development | GO:0007417 | 201 | 0.017 | |
| programmed cell death | GO:0012501 | 257 | 0.016 | Human |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.016 | |
| imaginal disc derived appendage development | GO:0048737 | 399 | 0.016 | |
| cell cycle phase transition | GO:0044770 | 140 | 0.016 | |
| appendage development | GO:0048736 | 401 | 0.016 | |
| protein transport | GO:0015031 | 155 | 0.015 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.015 | Human |
| eye morphogenesis | GO:0048592 | 260 | 0.015 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 145 | 0.015 | Human |
| negative regulation of cell cycle | GO:0045786 | 116 | 0.015 | Human |
| defense response | GO:0006952 | 300 | 0.015 | |
| compound eye development | GO:0048749 | 307 | 0.015 | |
| single organism catabolic process | GO:0044712 | 228 | 0.015 | |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.015 | |
| imaginal disc derived wing morphogenesis | GO:0007476 | 337 | 0.015 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.015 | |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 265 | 0.014 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 332 | 0.014 | Human |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.014 | Human |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.014 | |
| mitotic g2 m transition checkpoint | GO:0044818 | 70 | 0.014 | |
| taxis | GO:0042330 | 304 | 0.014 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.014 | |
| single organism membrane organization | GO:0044802 | 93 | 0.014 | |
| phagocytosis | GO:0006909 | 215 | 0.014 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.014 | |
| negative regulation of response to stimulus | GO:0048585 | 258 | 0.014 | |
| cellular amino acid metabolic process | GO:0006520 | 61 | 0.014 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.013 | |
| regulation of cell death | GO:0010941 | 173 | 0.013 | Human |
| macromolecular complex assembly | GO:0065003 | 256 | 0.013 | |
| single organism biosynthetic process | GO:0044711 | 206 | 0.013 | |
| regulation of cell differentiation | GO:0045595 | 302 | 0.013 | |
| chromatin modification | GO:0016568 | 147 | 0.013 | |
| negative regulation of developmental process | GO:0051093 | 201 | 0.013 | |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.013 | |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.013 | |
| mrna metabolic process | GO:0016071 | 124 | 0.012 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.012 | Human |
| positive regulation of transcription dna templated | GO:0045893 | 266 | 0.012 | Human |
| regulation of hydrolase activity | GO:0051336 | 97 | 0.012 | Human |
| amine metabolic process | GO:0009308 | 12 | 0.012 | |
| cellular amine metabolic process | GO:0044106 | 12 | 0.012 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.012 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.012 | |
| membrane organization | GO:0061024 | 112 | 0.012 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.012 | |
| regulation of cellular amine metabolic process | GO:0033238 | 3 | 0.012 | |
| endomembrane system organization | GO:0010256 | 119 | 0.012 | |
| chromatin remodeling | GO:0006338 | 72 | 0.011 | |
| actin filament based process | GO:0030029 | 220 | 0.011 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.011 | |
| stem cell differentiation | GO:0048863 | 117 | 0.011 | |
| negative regulation of signal transduction | GO:0009968 | 206 | 0.011 | |
| imaginal disc derived appendage morphogenesis | GO:0035114 | 395 | 0.011 | |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.011 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.011 | Human |
| positive regulation of molecular function | GO:0044093 | 136 | 0.011 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 117 | 0.011 | |
| gene silencing | GO:0016458 | 138 | 0.011 | |
| single organism cellular localization | GO:1902580 | 180 | 0.011 | |
| response to organic substance | GO:0010033 | 284 | 0.011 | |
| growth | GO:0040007 | 359 | 0.011 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 3 | 0.011 | |
| developmental growth | GO:0048589 | 280 | 0.011 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.011 | |
| response to other organism | GO:0051707 | 293 | 0.011 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 0 | 0.011 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 266 | 0.011 | Human |
| response to oxygen containing compound | GO:1901700 | 200 | 0.010 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.010 | |
| compound eye morphogenesis | GO:0001745 | 249 | 0.010 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.010 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 80 | 0.010 | |
| nucleoside catabolic process | GO:0009164 | 112 | 0.010 | |
| regulation of cellular component biogenesis | GO:0044087 | 201 | 0.010 | |
| regulation of response to stress | GO:0080134 | 200 | 0.010 | |
| organic acid metabolic process | GO:0006082 | 103 | 0.010 | |
| regulation of apoptotic process | GO:0042981 | 130 | 0.010 | Human |